Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Sees Large Volume Increase – Should You Buy?

Shares of Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) saw unusually-strong trading volume on Monday . Approximately 159,528 shares changed hands during mid-day trading, an increase of 740% from the previous session’s volume of 18,989 shares.The stock last traded at $22.86 and had previously closed at $19.50.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on TLX. UBS Group boosted their price objective on shares of Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. William Blair upgraded Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research report on Tuesday, November 19th.

Telix Pharmaceuticals Limited American Depositary Shares Stock Up 21.8 %

The business’s fifty day moving average price is $16.75.

About Telix Pharmaceuticals Limited American Depositary Shares

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.